Swedish Hospitality Stock News

On November 6, 2025, Telia Company announced a four-year extension of its Radio Access Network partnership with Ericsson, covering Sweden, Norway, Lithuania, and Estonia to enhance network performance and deploy advanced 5G capabilities across multiple sectors. This expanded collaboration underscores Ericsson’s role in supporting mission-critical communications, 5G innovation, and digital infrastructure modernization for industries and public services throughout the Nordic and Baltic...

Earlier this month, Camurus announced positive topline results from a Phase 1b trial evaluating CAM2056, its monthly FluidCrystal® semaglutide formulation, which demonstrated significant dose-dependent reductions in body weight, hemoglobin A1c, and fasting glucose in people with overweight or obesity, with efficacy comparable to or greater than weekly semaglutide. This study suggests CAM2056 could offer similar or stronger metabolic benefits with the convenience of monthly dosing,...

Earlier this month, AB SKF showcased its scalable clean technologies and circular solutions at COP30, receiving recognition for its remanufacturing initiatives as a winner of the Sustainable Business COP's Best Cases award. This award highlights SKF's advancement in industrial decarbonization, where innovative remanufacturing and oil regeneration technologies are reducing emissions and extending product lifecycles in heavy industry. We'll explore how the spotlight on SKF's award-winning...

BioArctic's partner Eisai recently announced the upcoming presentation of extensive new lecanemab (Leqembi) clinical and real-world data at the Clinical Trials on Alzheimer's Disease (CTAD) conference in San Diego from December 1-4, covering long-term treatment outcomes, subcutaneous administration, and real-world registry findings. These disclosures are expected to provide important insights into the long-term effectiveness, patient experience, and potential healthcare resource savings of...

Amidst a backdrop of mixed global market performances, the European markets recently saw a boost as major stock indexes rose, driven by relief over the reopening of the U.S. federal government. However, cooling sentiment around artificial intelligence investments has tempered gains in some sectors. In this environment, growth companies with high insider ownership can offer unique insights into potential opportunities, as insider confidence often signals alignment with shareholder interests...

In the past week, Saab AB announced several major defense contracts, including a €3.1 billion order for 17 Gripen E/F fighters from the Colombian Government, additional electronic warfare sensor suite orders from Airbus Defence and Space totaling approximately €549 million, and a SEK 510 million contract for Carl-Gustaf M4 deliveries to Denmark, alongside a new partnership with Ericsson Canada and Calian focused on advanced secure communications for Canadian defense. These developments...

Skanska (OM:SKA B) has been making headlines after landing major new contracts in Finland and the US. The company also reported a solid third quarter, marked by rising net income and continued sales growth. See our latest analysis for Skanska. Between headline-grabbing contract wins in Finland and the US and a robust earnings report, Skanska has caught the market’s eye, as reflected in its 1.9% year-to-date share price return and a 14.8% total shareholder return over the past year. While...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Alfa Laval (OM:ALFA) has expanded its long-running partnership with Electricite de France (EDF), aiming to support the latest wave of nuclear energy projects in France. Their new agreement centers on advanced heat exchanger technology and a streamlined, modular approach for upcoming EPR2 reactors. See our latest analysis for Alfa Laval. Alfa Laval’s renewed focus on advanced nuclear energy solutions comes as momentum in its share price has recently faded, with a 7.9% decline year-to-date and...

Embracer Group (OM:EMBRAC B) has just published its second quarter results, revealing a drop in sales and revenue compared to last year. However, the company managed to dramatically reduce its net loss year on year. See our latest analysis for Embracer Group. Embracer Group’s earnings release follows a challenging stretch for the shares, which have seen a sharp drop recently but a small recovery in the last 90 days. While the latest results show operational improvement, the 1-year total...

Electrolux Professional (OM:EPRO B) recently rolled out a series of strategic moves, including teaming up with Mimbly on water-efficient technologies, shifting cooking production to Italy, and releasing new sustainability-focused product lines. See our latest analysis for Electrolux Professional. The recent pace of Electrolux Professional’s innovation and operational changes seems to have drawn mixed reactions from the market. The share price has given back 6% over the past month, even as the...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Market forces rained on the parade of Camurus AB (publ) ( STO:CAMX ) shareholders today, when the analysts downgraded...

Essity (OM:ESSITY B) shares have edged up slightly over the past month, adding a bit more than 0.1%. Investors watching the Swedish hygiene and health company can note this modest uptick as broader market dynamics and sector shifts continue to play out. See our latest analysis for Essity. The share price recently slipped lower year-to-date but has started to show some stability. Although the 1-year total shareholder return sits at -9.3%, those who held on for the past three or five years have...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Nordnet AB (publ) reported that in October 2025, customers made 6,545,900 trades, net savings totaled SEK 7.7 billion, and the total savings capital reached SEK 1,176 billion. A key insight is the company's annual customer growth rate of 12.9%, bringing its customer base to over 2.31 million by the end of October. Given Nordnet's recent robust customer growth, we will examine how this positive momentum impacts the company's investment narrative and outlook. These 13 companies survived and...

The European stock market has experienced a positive upswing, with the pan-European STOXX Europe 600 Index rising by 1.77% as investors welcomed the reopening of the U.S. federal government, although enthusiasm was tempered by cooling sentiment around artificial intelligence investments. Against this backdrop, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential opportunities, particularly in an environment where economic indicators and investor...

With a price-to-earnings (or "P/E") ratio of 31.5x Beijer Alma AB (publ) ( STO:BEIA B ) may be sending bearish signals...

Anyone interested in Boozt AB (publ) ( STO:BOOZT ) should probably be aware that the Co-Founder & Group Chief Technical...

Potential RaySearch Laboratories AB (publ) ( STO:RAY B ) shareholders may wish to note that the Independent Director...

Medicover AB (publ) has reported its third quarter and nine-month results for the period ended September 30, 2025, with sales rising to €591.6 million in the quarter and net income turning positive year-on-year. This return to profitability, coupled with robust top-line growth, marks a marked turnaround in operational performance compared to the same period last year. We'll look at how Medicover's move from loss to profit may reshape the company's investment narrative and future...

Camurus (OM:CAMX) just released positive topline results from a Phase 1b trial testing its monthly GLP-1 candidate, CAM2056, against weekly semaglutide in people living with overweight or obesity. This outcome could have key implications for both the company and patients. See our latest analysis for Camurus. Camurus has captured investors’ attention lately, as excitement around the CAM2056 results helped drive a 3.5% share price gain in the last day and an impressive 18.1% return over the...